Opus Genetics, Inc.

NASDAQ:IRD

Biotechnology

Healthcare
$3.92 -0.12%

-$0.01 today

Market cap
$326.13M
Beta
0.55
P/E (TTM)
-33.0
EPS (TTM)
-$0.12
52W Low $0.90High $5.81

Volume 0.75M

Average 0.81M

Income Statement

Follow revenue through to earnings.

Revenue

$14.20M

FY 2025 · Annual

+29.1% YoY

Operating Income

-$38.60M

FY 2025 · Annual

Net Income

-$49.59M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue589K39.85M19.05M10.99M14.2M
Cost of Revenue00000
Gross Profit589K39.85M19.05M10.99M14.2M
Gross Margin100.0%100.0%100.0%100.0%100.0%
Research & Development15.17M14.36M17.65M26.85M30.81M
Selling, General & Admin8.12M7.27M11.96M18.22M21.98M
Operating Expenses23.29M21.62M29.61M73.07M52.8M
Depreciation & Amortization4K4K6K10K53K
EBITDA(56.69M)18.22M(9.97M)(57.52M)(48.07M)
EBITDA Margin-9624.3%45.7%-52.3%-523.3%-338.6%
Operating Income(22.71M)18.23M(10.56M)(62.07M)(38.6M)
Operating Margin-3854.8%45.7%-55.5%-564.7%-271.9%
Interest Income00000
Interest Expense2K9K1.33M01.47M
Other Income / Expenses(33.99M)(23K)589K4.54M(10.99M)
Income Before Tax(56.69M)18.2M(9.97M)(57.53M)(49.59M)
Pre-Tax Margin-9625.3%45.7%-52.4%-523.4%-349.3%
Income Tax Expense0315K12K00
Net Income(56.69M)17.89M(9.99M)(57.53M)(49.59M)
Net Margin-9625.3%44.9%-52.4%-523.4%-349.3%
EPS (Basic)(3.82)0.90(0.46)(2.15)(0.80)
EPS (Diluted)(3.82)0.87(0.46)(2.15)(0.80)
Weighted Avg Shares14.85M19.93M21.59M26.72M622.22M
Weighted Avg Shares (Diluted)14.85M20.6M21.59M26.72M622.22M

IRD Earnings Waterfall · TTM

NASDAQ:IRD · Revenue to Net Income

Key Ratios

EPS$-1.31
Gross Margin47.6%
Net Margin-1072.5%
P/E Ratio-9.4
P/S Ratio553.8

Analysis

$12.0M of revenue converted into -$106.9M of net income for the selected period. Gross margin is 47.6% and net margin is -1072.5%, showing how much revenue survives after costs and taxes. EPS is $-1.31, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 12, 2026
8-KCurrent reportNov 10, 2026
10-QQuarterly reportNov 10, 2026
4Statement of changes in beneficial ownershipNov 5, 2026
4Statement of changes in beneficial ownershipOct 27, 2026

How much revenue does IRD generate?

Opus Genetics, Inc. (IRD) reported $14.20M of revenue in fiscal 2025.

Is IRD profitable?

Opus Genetics, Inc. (IRD) reported -$49.59M of net income, with a net margin of -349.3%.